Evidence map›Paper›PMID 42884016›Full record

ArticleInternational journal of molecular sciences2026

Features of Complementary Interactions of BmiRNAs with mRNAs of Human Genes.

Anatoliy Ivashchenko, Anna Pyrkova, Saltanat Orazova, Raigul Niyazova

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anatoliy IvashchenkoDepartment of Biotechnology, Farabi University, Almaty 050040, Kazakhstan.ORCID 0000-0002-7969-2016
Anna PyrkovaDepartment of Computer Sciences, Farabi University, Almaty 050040, Kazakhstan.ORCID 0000-0001-8483-451X
Saltanat OrazovaDepartment of Biotechnology, Farabi University, Almaty 050040, Kazakhstan.ORCID 0000-0003-4380-2460
Raigul NiyazovaDepartment of Biotechnology, Farabi University, Almaty 050040, Kazakhstan.ORCID 0000-0002-7946-1189

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakh-stan AP26102055
6 · The paper itself

Abstract

More than three decades have passed since the discovery of miRNAs in human cells, yet many of their biological properties remain poorly understood. The aim of this study was to investigate whether miRNAs can interact with target gene mRNAs through fully complementary base pairing. Using the MirTarget program, we demonstrated that all nucleotides of miRNAs can form fully complementary interactions with nucleotides of target gene mRNAs. A total of 1036 miRNAs, which were identified by Backes et al. and we designated as BmiRNAs and mRNAs from 17,508 human genes, were analyzed, revealing several important characteristics. The vast majority of BmiRNAs were found to bind fully complementarily to the 3'-untranslated regions (3'UTRs) of target gene mRNAs. Many mRNAs contained binding sites (BSs) for multiple BmiRNAs, forming binding site clusters in which BmiRNAs may compete for interaction with the same mRNA. We also identified identical groups of up to four BmiRNAs capable of binding to the mRNAs of different genes. In addition, genes whose mRNAs contained up to eight BmiRNA binding sites were identified. These findings broaden our understanding of the mechanisms by which BmiRNAs regulate human gene expression at the mRNA translation stage and provide new insights into their potential role in post-transcriptional gene regulation.

Indexed as

MicroRNAsRNA, Messenger3' Untranslated RegionsBinding SitesGene Expression RegulationHumans3' Untranslated RegionsMicroRNAsRNA, Messengerhuman genesmiRNAmiRNA-mRNA interactionmRNA

Identifiers

PMID42884016
PMCPMC13665148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.